• 1
    Marcellin P. Hepatitis C: the clinical spectrum of the disease. J Hepatol 1999; 31: 916.
  • 2
    EASL International Consensus Conference on Hepatitis C, consensus statement. J Hepatol 1999; 31(Suppl 1): 38.
  • 3
    Ghany MG, Kleiner DE, Alter H, Doo E, Khokar F, Promrat K, et al. Progression of fibrosis in chronic hepatitis C. Gastroenterology 2003; 124: 97104.
  • 4
    Ryder SD, on behalf of the Trent Hepatitis C study Group. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 2004; 53: 451455.
  • 5
    Zarski JP, McHutchison J, Bronowicki JP, Sturm N, Garcia-Kennedy R, Enkelejda H, et al. Rate of natural disease progression in patients with chronic hepatitis C. J Hepatol 2003; 38: 307314.
  • 6
    Westin J, Nordlinder H, Lagging M, Norkrans G, Wejstal R. Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients. J Hepatol 2002; 37: 837842.
  • 7
    Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Bodenheimer HC Jr, et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 1993; 104: 595603.
  • 8
    Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. HEPATOLOGY 1992; 15: 567571.
  • 9
    Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. HEPATOLOGY 1992; 15: 572577.
  • 10
    Serfaty L, Poujol-Robert A, Carbonell N, Chazouillères O, Poupon RE, Poupon R. Liver fibrosis in chronic hepatitis C: evidence for a synergistic interaction between steatosis and alcohol intake. Am J Gastroenterol 2002; 97: 18071812.
    Direct Link:
  • 11
    Castera L, Hézode C, Roudot-Thoraval F, Bastie A, Zafrani E-S, Pawlotsky J-M, et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003; 52: 288292.
  • 12
    Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. HEPATOLOGY 2001; 33: 13581364.
  • 13
    Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Clouston A, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999; 29: 12151219.
  • 14
    Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 1996; 42: 558563.
  • 15
    Bedossa P, Poynard T, The METAVIR Cooperative study group. An algorithm for the grading of activity in chronic hepatitis C. HEPATOLOGY 1996; 24: 289293.
  • 16
    Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. HEPATOLOGY 2003; 38: 13561358.
  • 17
    Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001; 34: 730739.
  • 18
    Hui CK, Belaye T, Montegrande K, Wright TL. A comparaison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase. J Hepatol 2003; 38: 511517.
  • 19
    Serfaty L, Andreani T, Giral P, Carbonell N, Chazouillères O, Poupon R. Hepatitis C virus induced hypobetalipoproteinemia : a possible mechanism for steatosis in chronic hepatitis C. J Hepatol 2001; 34: 428434.